期刊文献+

心包腔内置管引流并注入顺铂对恶性心包积液的治疗效果 被引量:2

The heart wraps to place a tube to lead to flow inside the chamber and infuse into agreeable platinum to malignant heart pack the treatment effect that accumulate a liquid
原文传递
导出
摘要 目的:观察心包腔内置管引流并注入顺铂治疗恶性心包积液的临床疗效。方法:回顾性分析对23例恶性心包积液的患者,采用中心静脉导管经皮心包穿刺留置引流心包积液,待充分引流后注入顺铂。结果:所有患者一次穿刺置管引流成功,无严重并发症,完全缓解7例,部分缓解13例,无效3例,总有效率86.95%。23例患者中位生存期为153 d(35~731 d)。结论:心包腔内置管引流并注入顺铂治疗恶性心包积液安全有效,能够改善预后,延长生存,值得临床推广应用。 Objective To observe the pericardial cavity drainage and injection of clinical curative effect of cisplatin in the treatment of malignant pericardial effusion.Methods A retrospective analysis of 23 cases with malignant hydropericardium in patients with,the use of percutaneous pericardial puncture and indwelling central venous catheter drainage for pericardial effusion,be sufficient drainage after injection of cisplatin.Results All patients with a puncture catheter drainage success,no serious complications,complete remission in 7 cases,some 13 cases,is not valid in 3 cases,total effective rate 86.9%.Lifetime 153D in 23 patients(35-731d).Conclusion The pericardial cavity drainage and injection and cisplatin in the treatment of malignant pericardial effusion,safe and effective,can improve the prognosis,extended life,and clinical application.
出处 《湖南师范大学学报(医学版)》 2012年第1期50-52,共3页 Journal of Hunan Normal University(Medical Sciences)
关键词 心包腔内置管 顺铂 恶性心包积液 The heart wraps to place a tube inside the chamber agreeable platinum The malignant heart pack accumulates a liquid
  • 相关文献

参考文献7

二级参考文献21

  • 1周雪峰,潘骥群,陈卫宏,张霞,季祥.经皮心包腔内置管化疗治疗恶性心包积液[J].临床肿瘤学杂志,2005,10(1):97-98. 被引量:11
  • 2杨曙光,苏玉文,张燕,田银君.心包穿刺置管引流治疗心包积液和心包填塞38例[J].人民军医,2005,48(3):152-153. 被引量:2
  • 3徐光炜(译).临床肿瘤学[M].沈阳:辽宁教育出版社,1999.694.
  • 4Gross J L,Younes R N,Deheinzelin D,Diniz A L,Silva R A,Haddad F J.Surgical management of symptomatic pericardial effusion in patients with solid malignancies EJ3.Ann Surg On-col,2006,13:1732-1738.
  • 5廖美琳.肺癌现代治疗学[M].上海:上海医科大学出版社,1995:139-142.
  • 6Ben-Horin S,Bank I,Guetta V,Livneh A.Large symptomatic pericardial effusion as the presentation of unrecognized cancer:a study in 173 consecutive patients undergoing pericardiocente-sis[J].Medicine(Baltimore),2006,85:49-53.
  • 7Dequanter D,Lothaire P,Berghmans T,Sculier J P.Severe per-ieardial effusion in patients with concurrent malignancy:a ret-rospective analysis of prognostic factors influencing survival.[J].Ann Surg Oncol,2008,15:3268-3271.
  • 8Laham R J,Cohen D J,Kuntz R E,Baim D S,Lorell B H,Si-mons M.Pericardial effusion in patients with cancer:outcome with contemporary management strategies[J].Heart,1996,75:67-71.
  • 9Maruyama R,Yokoyama H,Seto T·Nagashima S,Kashiwabara K.Araki J.Catheter drainage followed by xhe instillation of ble-omycin to manage malignant pericardial effusion in non-small cell lung cancer:a multi-institutional phase II trial[J].J Tho-rac Oncol,2007,2:65-68.
  • 10Kaira K,Takise A,Kobayashi G,Utsugi M,Horie T,Mori T,et al.Management of malignant perieardial effusion with instil-lation of mitomycin C in non-small cell lung cancer[J].Jpn J Clin Oncol,2005,35:57-60.

共引文献71

同被引文献25

  • 1江跃全,陈诗奉.胸腔镜心包开窗术对恶性心包积液的治疗价值[J].临床外科杂志,2004,12(10):620-621. 被引量:4
  • 2王朝霞,陆彬彬,王腾,德伟,束永前.重组人p53腺病毒注射液(今又生)对人肺腺癌细胞生长及化疗敏感性研究[J].中国肺癌杂志,2006,9(2):127-131. 被引量:16
  • 3吴艳芳,于雷,王金万.恶性心包积液的内科治疗进展[J].癌症进展,2007,5(4):352-354. 被引量:25
  • 4Brigden ML. Hematologic and oncologic emergencies.Doing the most good in the least time[J].Postgrad M ed,2001,(3):143-146.
  • 5Hong CY,Huang SC,Lin SK. Norcantharidin-induced post-G (2)/M apoptosis is dependent on wild-type p53 gene[J].{H}Biochemical and Biophysical Research Communications,2000,(1):278-285.
  • 6Buller RE,Runnebaum IB,Karlan BY. A phase Ⅰ / Ⅱ trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer[J].{H}Cancer Gene Therapy,2002,(7):553-566.
  • 7Osaki S,Nakanishi Y,Takayama K. Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of thewild-type p53 gene in human lung cancer cells[J].{H}Cancer Gene Therapy,2000,(2):300-307.
  • 8Horio Y,Hasegawa Y,Sekido Y. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of nonsmall cell lung cancer cells[J].{H}Cancer Gene Therapy,2000,(4):537-544.
  • 9Bálint EE,Vousden KH. Activation and activities of the p53tumour suppressor protein[J].{H}British Journal of Cancer,2001,(12):1813-1823.
  • 10Ajani Jaffer A,Lee Fa-Chyi,Singh Deepti A,Haller Daniel G,Lenz Heinz-Josef,Benson Al B,Yanagihara Ronald,Phan Alexandria T,Yao James C,Strumberg Dirk.Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2006

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部